Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan

INTRODUCTION: This post-marketing observational interim analysis evaluated the 12-month effectiveness and safety of omidenepag isopropyl (OMDI) ophthalmic solution in daily clinical settings. METHODS: This was a multicenter, large-scale, non-interventional, prospective, observational study conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakazawa, Toru, Takahashi, Kanji, Kuwayama, Yasuaki, Nomura, Akio, Shimada, Fumiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918093/
https://www.ncbi.nlm.nih.gov/pubmed/35072890
http://dx.doi.org/10.1007/s12325-021-02035-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918093/
https://www.ncbi.nlm.nih.gov/pubmed/35072890
http://dx.doi.org/10.1007/s12325-021-02035-8

Ejemplares similares